News

ChainCatcher news, according to on-chain analyst Ember (@EmberCN), the controlling party of SIREN has consolidated tokens scattered across hundreds of wallets into 48 wallets in the past few hours, involving approximately 484.6 million tokens, accounting for 66.5% of the total supply, with a current value of about $1.04 billions.

Odaily reported that trader 0xSun posted on the X platform, stating that the current popularity and concentration of resources in the AI industry are significantly higher than in Crypto, but the two have different positioning. He pointed out that although tracks such as NFT and GameFi have not met expectations, Crypto is still achieving practical applications in areas like stablecoin cross-border payments, RWA, and BTC. He believes that compared to traditional technology industries, Crypto offers a more open value distribution mechanism, allowing ordinary users to gain potential returns by participating in projects early, whereas the dividends in the AI industry are more concentrated among leading institutions and talent. Additionally, he stated that he will pay attention to investment opportunities related to both Crypto and AI, gradually expanding into AI and US stocks while maintaining his focus on the crypto industry.

The company has updated the expected release date for key clinical results of the phase 2/3 OPTIMUM-02 trial for Darovasertib. This update provides the market with a clearer timeline, helping investors better assess the potential value of this drug in the treatment of uveal melanoma. As an important asset in IDEAYA's research pipeline, the clinical progress of Darovasertib has always attracted industry attention. With investor relations activities approaching, the company's management expects to engage in in-depth communication with the market on key topics such as R&D strategy, pipeline layout, and commercialization preparations. These developments will provide the market with a new perspective for evaluating IDEAYA's future growth.